Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection - Wikidata - wikimedia - TriplyDB

Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection

Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection

http://www.wikidata.org/entity/Q33591425

about

Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration Surfactant phospholipid metabolism New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs Respiratory epithelial cells orchestrate pulmonary innate immunity.Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1 Pulmonary surfactant pathophysiology: current models and open questions Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease Role for phospholipid acyl chains and cholesterol in pulmonary infections and inflammation Surfactant and its role in the pathobiology of pulmonary infection FTIR metabolomic fingerprint reveals different modes of action exerted by structural variants of N-alkyltropinium bromide surfactants on Escherichia coli and Listeria innocua cells SP-B and SP-C containing new synthetic surfactant for treatment of extremely immature lamb lung Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung.TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease.MALDI imaging MS of phospholipids in the mouse lung MALDI imaging of lipid biochemistry in tissues by mass spectrometry.Review: Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation.CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance.Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice Phosphatidylinositol inhibits respiratory syncytial virus infection Distinct effects of different phosphatidylglycerol species on mouse keratinocyte proliferation.Ion Mobility and Tandem Mass Spectrometry of Phosphatidylglycerol and Bis(monoacylglycerol)phosphate (BMP).Anionic pulmonary surfactant lipid regulation of innate immunity Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes.Phosphatidylglycerol suppresses influenza A virus infection Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics Genetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injury Molecular structures of fluid phase phosphatidylglycerol bilayers as determined by small angle neutron and X-ray scattering.Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit toll-like receptor 2 and 4 signaling.Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection.Targeting RSV with vaccines and small molecule drugs.Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS Pattern recognition receptors and genetic risk for rsv infection: value for clinical decision-making?Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.Toll-like receptors in neonatal sepsis.Immunomodulatory properties of surfactant preparations.Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections Lipidomic characterization and localization of phospholipids in the human lung.Is phosphatidylglycerol essential for terrestrial life?

P2860

Q23909704-EB8DDEE9-F418-4977-B5B7-CC5EA29DBD81 Q26826812-37AA22EC-CD89-4064-80B4-EDAD158CE06E Q27313764-DB2EF361-FF7D-4FC4-9F90-2536F3F89190 Q27687743-CBB14782-BC47-48FA-A579-374B9A65ED17 Q28249812-12EDCD12-FFE6-457A-8692-0A6412094126 Q28285439-80ACF420-097E-49B1-A9DD-79B995973BEE Q28383936-23C956F8-FE98-455C-9576-A6012F92586E Q28391857-3FF00150-4FB0-4C8F-9E8D-2269FAC0C8F8 Q28395117-83E3876D-239A-44D7-9D2C-ACE4E4C3FEAE Q28543020-23CC90CF-0283-4DCE-B4F0-34A454966B13 Q28727044-0C37026D-00E3-4823-A7C0-9D67FD8F354B Q30431169-BA6ECBCB-E5EB-436B-8C38-014F27D7E2E7 Q33658939-B737665F-0776-4F4D-8151-5BE342EEFFDB Q33727344-683B2642-AD1A-4CFB-91F7-D3861BB63BFE Q33878265-016CF953-A988-42BD-8C7A-15DD146BCC44 Q34028743-1512B818-D214-4CAB-8B99-EA350FE1B8CD Q34119510-B588BFC5-7439-4C0F-82DA-611C8D39859E Q34188075-E58E9D47-82B6-415D-A4A4-5EE29C6E0C0F Q34624136-9AAD6671-21D6-4902-A79D-6252A3566021 Q34839285-90437A64-B09E-471E-92F7-B018A86BBEAA Q35120910-711F785D-3390-480E-A5F0-31D5CFA400A5 Q35262169-C6743EB5-9E1D-4907-937F-6EB8A71453EA Q35379696-4FAE47F5-6C7A-482B-B75E-1674F360DEBA Q35648698-D1ED3E41-7E4D-4BCA-BBE1-6D79F30C47CD Q35899095-FC779FA1-A935-4AA2-BB75-0FF4D2F6B2E5 Q35987319-ECABFD11-BD19-4A80-85FF-855CAC9AFF96 Q36174346-8EF15271-03B3-41AC-8298-9C046230DCB0 Q36687847-83965800-ACB7-43B2-8777-5880BCF67D20 Q36904617-1E8B451F-E79B-4243-AC01-60584B6C90A5 Q36930183-2F9E6F99-3EC2-4B51-BA59-598AC9BD9BE7 Q37002647-FA3F5551-1641-4257-B04F-73B132DC0105 Q37328584-342AAE88-7BD9-4980-A878-B8A402B8C300 Q37466166-AE626537-7E84-4D72-9CB2-3FB727E4FEF2 Q37801887-EF64483F-58DD-4E7A-818D-60EF68C04C9E Q38067753-5AB29E5A-32DF-431B-8217-3C482D0E7EA7 Q38082543-075E68CB-8358-4C38-978C-06DDFF372C1C Q38083316-56816830-2B89-4DE2-882D-1E01174A316B Q38163544-17789D07-C6F8-488D-94C1-629CD72AF419 Q38916413-D595655C-6916-4CBE-999D-1C88AAE32FAD Q39013532-90C45A9A-FB0A-454E-9A27-DD37BFC6F1A4

P2860

Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection

http://www.wikidata.org/entity/Q33591425

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Pulmonary surfactant phosphati ...... ced inflammation and infection

@ast

Pulmonary surfactant phosphati ...... ced inflammation and infection

@en

type

label

Pulmonary surfactant phosphati ...... ced inflammation and infection

@ast

Pulmonary surfactant phosphati ...... ced inflammation and infection

@en

prefLabel

Pulmonary surfactant phosphati ...... ced inflammation and infection

@ast

Pulmonary surfactant phosphati ...... ced inflammation and infection

@en

P1433

Q33591425-AAB6AA14-72EF-4DDC-A2F8-0ECB4673CB92

P1476

Q33591425-6434815E-FF9E-4804-8B0B-EEB5DCB12A64

P2093

Q33591425-25486736-9CA7-493E-9D9C-9488BEF39912

Q33591425-899AD6F1-2B38-492B-A8AA-626230439880

Q33591425-8A695C64-DB4F-45F2-BA92-B044E6DB829C

P2860

Q33591425-010827D1-553B-45B2-AD46-183F92D43FC1

Q33591425-0A3ED1C1-FA71-4EB3-AA4A-023F67CED610

Q33591425-153833D9-09E1-4FD3-BBAA-4D816042821E

Q33591425-17B6637E-FB49-4B84-9301-6840DEEAFF13

Q33591425-1F220AA4-5093-4CF7-9044-4F2E7AA56CDD

Q33591425-29FF87A1-2676-4FDA-B93E-EE4732247E91

Q33591425-2AAD506E-244E-4C2C-BFA6-D7EE843BB59D

Q33591425-2D83B4E8-51A9-4F4D-8917-26095A24F0EB

Q33591425-40095B32-62F4-4C64-9636-CCEFC9AB6A8B

Q33591425-5BD18138-450D-49C0-B3E3-EA402D7DA64B

P304

Q33591425-BE451056-4789-47C4-B2FA-B1DD9A736136

P31

Q33591425-FDC56BA3-9EDF-4CD2-A3E5-ABC9C5053759

P356

Q33591425-EE55E11C-F27E-4E2C-BD4C-90B7210A4E9D

P407

Q33591425-11D9388A-A220-4D59-AB10-446D7FFB4473

P433

Q33591425-B83CD14C-23B9-4D99-97D7-11E63066BEEA

P478

Q33591425-70A77D9F-B078-46BE-B265-5AF14015EC94

P50

Q33591425-99F49B54-B571-4C90-A541-785C96A18555

P577

Q33591425-27CBFC14-AA6B-46C4-9A80-AA0AA46CB8E6

P5875

Q33591425-553FF4E4-DB36-4CD3-AF65-BEAD6C214EE9

P698

Q33591425-54AA8097-AC09-4960-BF3F-1C0158323938

P932

Q33591425-DB2A4B60-9EBA-40B8-8F4D-06E106FC274A

P356

PNAS.0909361107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Pulmonary surfactant phosphati ...... ced inflammation and infection

@en

P2093

Dennis R Voelker

http://www.w3.org/2001/XMLSchema#string

Hong Wei Chu

http://www.w3.org/2001/XMLSchema#string

Mari Numata

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor signalling

Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution.

Respiratory syncytial virus and parainfluenza virus.

Respiratory syncytial virus infections in immunocompromised adults.

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

siRNAs: applications in functional genomics and potential as therapeutics.

Activation of airway epithelial cells by toll-like receptor agonists.

Respiratory syncytial virus infection in elderly and high-risk adults.

Exacerbations: etiology and pathophysiologic mechanisms.

Respiratory viruses and exacerbations of asthma in adults.

P304

320-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0909361107

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Azzeddine Dakhama

P577

2009-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41040466

http://www.w3.org/2001/XMLSchema#string

P698

20080799

http://www.w3.org/2001/XMLSchema#string

P932

2806703

http://www.w3.org/2001/XMLSchema#string